The SURMOUNT-1 DXA substudy found that tirzepatide produced a 33.9% reduction in fat mass and a 10.9% reduction in lean mass over 72 weeks, with approximately 75% of total weight lost coming from fat and 25% from lean mass
Gastroenterology 151 (5), 945960.e6
We also include InBody body composition scans to track fat loss, muscle retention, and hydration
Organ toxicity : Fenfluramine damaged heart valves
"My hope would be that commercial insurance would follow." In a statement, a CMS spokesperson said: "CMS is committed to ensuring that people have access to treatments and treatment options that improve health outcomes." The Medicare guidance could also expand the use of other similar medicines
In clinical trials, approximately 5-10% of semaglutide users reported experiencing dry mouth, making it a relatively common complaint